Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays a revision tag of v3.5.4, replacing the previous v3.5.3, indicating a minor update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-05-15T23:53:03.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s footer/version label has been updated from Revision: v3.5.2 to Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T16:48:33.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T13:32:09.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T19:12:23.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T15:26:22.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. The lapse-in-government-funding notice and the earlier Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:20:09.000Z thumbnail image

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.